Surgery for T4 non-small cell lung cancer

Surgery for non-small cell lung cancer.

BACKGROUND As part of an evaluation of the lung cancer surgery at Akershus University hospital we wanted to describe the lung cancer surgery programme, assess 30-day mortality and review complications. MATERIAL AND METHOD We retrospectively examined medical records of all patients undergoing potentially curative surgery for non-small-cell lung cancer. RESULTS The 99 patients operated on wer...

Complete resection in non-small cell lung cancer surgery.

Perspectives in Surgery of Oligometastatic Non-small-cell Lung Cancer

20-50% of patients with newly diagnosed non-small-cell lung cancer (NSCLC) have synchronous metastases. This dramatically affects survival and traditionally excludes patients from the spectrum of curative therapies. Nonetheless, studies have been performed to assess the role of surgery in Stage 4 NSCLC with metastases circumscribed to a single or limited number of organs, proposing the definiti...

Delays to surgery in non-small-cell lung cancer.

BACKGROUND In Canada, waiting times for referral and surgery exist for both benign and malignant disease. We attempted to evaluate the length of various waiting times for surgery as well as their association with surgical stage in patients with non-small-cell lung cancer (NSCLC). METHODS This observational study consisted of a retrospective review of data for all patients who underwent an ope...

[T2N1M0 non-small cell lung cancer: surgery and prognostic factors].

OBJECTIVE To determine the prognostic factors for the survival in a group of patients operated on for a non-small cell lung cancer classified as T2N1M0. PATIENTS AND METHODS Two hundred sixteen patients treated exclusively with surgery were studied. Kaplan-Meier survival and Cox multivariable regression analyses were used. RESULTS The overall survival rate was 39.8% at 5 years and 29.9% at ...